Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Annals of the Rheumatic Diseases|August 23, 2025
Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapyJulien De Lima, Marie-Astrid Boutet, Olivier Bortolotti, et al.Proceedings of the National Academy of Sciences of the United States of America|September 9, 2025
Synovial MS4A4A correlates with inflammation and counteracts response to corticosteroids in arthritisMarie-Astrid Boutet, Irene Mattiola, Rita Silva-Gomes, et al.Science Advances|September 25, 2024
Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onsetMegan M Hanlon, Conor M Smith, Mary Canavan, et al.Nature Medicine|May 19, 2022
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trialFelice Rivellese, Anna E A Surace, Katriona Goldmann, et al.Rheumatology (Oxford, England)|March 3, 2019
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritisElizabeth M A Hensor, Paul McKeigue, Stephanie F Ling, et al.Annals of the Rheumatic Diseases|June 21, 2023
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritisMaximilian Kugler, Mirjam Dellinger, Felix Kartnig, et al.Nature Immunology|March 21, 2019
Activation of naïve CD4+ T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4+ T cellsJason P Twohig, Ana Cardus Figueras, Robert Andrews, et al.Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Machine Learning Reveals Synovial Fibroblast Genes Associated with Pain Affect Sensory Nerve Growth in Rheumatoid ArthritisZilong Bai, Nicholas Bartelo, Maryam Aslam, et al.EMBO Reports|June 25, 2024
Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissuesLoïc Rolas, Monja Stein, Anna Barkaway, et al.Lancet (London, England)|January 24, 2021
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Patrick Durez, Maya H Buch, et al.Pageof 7